Togtema, M.; Hussack, G.; Dayer, G.; Teghtmeyer, M.R.; Raphael, S.; Tanha, J.; Zehbe, I.
Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein. Int. J. Mol. Sci. 2019, 20, 2088.
https://doi.org/10.3390/ijms20092088
AMA Style
Togtema M, Hussack G, Dayer G, Teghtmeyer MR, Raphael S, Tanha J, Zehbe I.
Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein. International Journal of Molecular Sciences. 2019; 20(9):2088.
https://doi.org/10.3390/ijms20092088
Chicago/Turabian Style
Togtema, Melissa, Greg Hussack, Guillem Dayer, Megan R. Teghtmeyer, Shalini Raphael, Jamshid Tanha, and Ingeborg Zehbe.
2019. "Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein" International Journal of Molecular Sciences 20, no. 9: 2088.
https://doi.org/10.3390/ijms20092088
APA Style
Togtema, M., Hussack, G., Dayer, G., Teghtmeyer, M. R., Raphael, S., Tanha, J., & Zehbe, I.
(2019). Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein. International Journal of Molecular Sciences, 20(9), 2088.
https://doi.org/10.3390/ijms20092088